Amber Capone News Today

For D. Wesley Applebury, the pandemic years meant overcoming crushing personal traumas in the midst of global tumult. In early 2020, at the age of 27,

The VA announced in January it will fund studies into the use of psychedelics for treating post traumatic stress disorder in military veterans.

After half-a-century of prohibition, the United States is about to legalize psilocybin and MDMA for clinical use, to treat people suffering from post-traumatic stress disorder or terminal cancer. Scientists, patients, clandestine therapists and war veterans speak with EL PAÍS about the bright spots and shadows of this rebirth

California researchers say just one dose of ibogaine administered orally eased mental health problems in 30 US veterans - whose symptoms did not return one month after treatment.

The study comes on the heels of legislation meant to explore the medicinal properties of numerous psychedelics.

In combat veterans, a single dose of ibogaine also improved symptoms of PTSD, depression and anxiety

The study by Stanford researchers is the first to explore the use of the psychedelic ibogaine to repair traumatic brain injury.

/PRNewswire/ - Today, Nature Medicine published the results of a clinical trial, in which 30 former Navy SEALs were administered ibogaine at Ambio Life...

The study comes on the heels of legislation meant to explore the medicinal properties of numerous psychedelics.

The study comes on the heels of legislation meant to explore the medicinal properties of numerous psychedelics.